119 related articles for article (PubMed ID: 38493943)
1. A method for measuring serum levels of melanin-associated indole metabolites using LC-MS/MS and its application to malignant melanoma.
Takiwaki M; Umemura H; Kikutani Y; Fukuzawa S; Abe K; Fujino K; Sugihara S; Tachibana K; Morizane S; Satoh M; Nakayama T; Yamasaki O
Clin Chim Acta; 2024 Apr; 557():117873. PubMed ID: 38493943
[TBL] [Abstract][Full Text] [Related]
2. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of melanin-related metabolites as markers of melanoma progression.
Horikoshi T; Ito S; Wakamatsu K; Onodera H; Eguchi H
Cancer; 1994 Feb; 73(3):629-36. PubMed ID: 8299084
[TBL] [Abstract][Full Text] [Related]
4. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma.
Hara H; Walsh N; Yamada K; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):501-5. PubMed ID: 8151128
[TBL] [Abstract][Full Text] [Related]
5. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
Pavel S; Muskiet FA
Cancer Detect Prev; 1983; 6(1-2):311-6. PubMed ID: 6883388
[TBL] [Abstract][Full Text] [Related]
6. Cysteine and indole derivatives as markers for malignant melanoma.
Hartleb J; Arndt R
J Chromatogr B Biomed Sci Appl; 2001 Nov; 764(1-2):409-43. PubMed ID: 11817040
[TBL] [Abstract][Full Text] [Related]
7. Determination of eumelanin in human urine.
Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
[TBL] [Abstract][Full Text] [Related]
8. Serum 5-S-cysteinyldopa (5-S-CD) as a marker of melanoma progression.
Horikoshi T; Ito S
J Dermatol; 1992 Nov; 19(11):809-13. PubMed ID: 1293168
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
Meyerhöffer S; Lindberg Z; Häger A; Kågedal B; Rosdahl I
Acta Derm Venereol; 1998 Jan; 78(1):31-5. PubMed ID: 9498023
[TBL] [Abstract][Full Text] [Related]
10. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
11. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
Wakamatsu K; Ito S
Pigment Cell Res; 2006 Oct; 19(5):460-4. PubMed ID: 16965276
[TBL] [Abstract][Full Text] [Related]
13. Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese.
Wakamatsu K; Ito S
Pigment Cell Res; 1995 Jun; 8(3):132-4. PubMed ID: 7567788
[TBL] [Abstract][Full Text] [Related]
14. Melanin-related metabolites as markers of the skin pigmentary system.
Westerhof W; Pavel S; Kammeyer A; Beusenberg FD; Cormane R
J Invest Dermatol; 1987 Jul; 89(1):78-81. PubMed ID: 3598203
[TBL] [Abstract][Full Text] [Related]
15. Generalized melanosis in metastatic malignant melanoma: the possible role of DOPAquinone metabolites.
Tsukamoto K; Furue M; Sato Y; Takayama O; Akasu R; Ohtake N; Wakamatsu K; Ito S; Tamaki K; Shimada S
Dermatology; 1998; 197(4):338-42. PubMed ID: 9873171
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of creatinine and creatine in human serum by double-spike isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) and gas chromatography-mass spectrometry (GC-MS).
Fernández-Fernández M; Rodríguez-González P; Añón Álvarez ME; Rodríguez F; Menéndez FV; García Alonso JI
Anal Chem; 2015 Apr; 87(7):3755-63. PubMed ID: 25751287
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using isotope dilution liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
Tai SS; Welch MJ
Anal Chem; 2004 Feb; 76(4):1008-14. PubMed ID: 14961732
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of plasma metanephrines using isotope dilution liquid chromatography tandem mass spectrometry (ID-LC/MS/MS): a candidate reference measurement procedure and its application to evaluating routine ID-LC/MS/MS methods.
Liu Z; Liu Q; Deng Y; Zhao H; Zeng J; Zhang T; Zhang J; Wang J; Zhou W; Zhang C
Anal Bioanal Chem; 2021 Dec; 413(30):7509-7520. PubMed ID: 34643770
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma.
Nijenhuis CM; Rosing H; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2014 Jan; 88():630-5. PubMed ID: 24216282
[TBL] [Abstract][Full Text] [Related]
20. An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of aldosterone in human serum and plasma.
Taibon J; Santner T; Singh N; Ibrahim SC; Babitzki G; Köppl D; Gaudl A; Geistanger A; Ceglarek U; Rauh M; Geletneky C
Clin Chem Lab Med; 2023 Oct; 61(11):1902-1916. PubMed ID: 36952682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
